Sign in

CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company

Emmaus Life Sciences, Inc.

Sign in to watch
Ticker
EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870419387
Phone
310-214-0065
Business address
21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
Former names
MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy Director bought 40,000 shares at an average $4.25 ($170,000)
  4. 8-K Event Delisting notice · Other events
  5. 4/A Open-market buy Chairman and CEO bought 20,000 shares at $3.19 ($63,800)
  6. 4 Open-market buy Director bought 12,545 shares at $4.20 ($52,689)
  7. 4/A Open-market buy Chairman and CEO bought 30,000 shares at an average $2.65 ($79,418)
  8. 4/A Open-market buy Chairman and CEO bought 10,000 shares at an average $2.97 ($29,740)
  9. 4/A Open-market buy Chairman and CEO bought 19,500 shares at an average $3.38 ($65,975)
  10. 3/A Insider 3/A
  11. 4 Open-market buy Chairman and CEO bought 32,499 shares at an average $4.03 ($130,918)
  12. 4 Open-market buy Director bought 52,892 shares at an average $3.89 ($205,700)
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 4 Open-market buy Director bought 3,400 shares at $3.30 ($11,220)
  15. 4 Open-market buy Chairman and CEO bought 20,000 shares at an average $3.19 ($63,831)
  16. 4 Open-market buy Director bought 2,345 shares at $2.80 ($6,566)
  17. 4 Open-market buy Vice Chairman & COO bought 600 shares at $2.62 ($1,572)
  18. 4 Open-market buy Chairman and CEO bought 8,300 shares at an average $2.64 ($21,907)
  19. 4 Open-market buy Chairman and CEO bought 31,700 shares at an average $2.76 ($87,386)
  20. SC 13G Stake Amended Statement of Ownership

Page 17 of 63 · 1,250 filings